{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:29:31Z","timestamp":1789345771959,"version":"build-2803163510"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Rheumatic heart disease (RHD) remains a significant cardiovascular burden in the world even though it is no longer common in affluent countries. Centuries of history surrounding this disease provide us with a thorough understanding of its pathophysiology. Infections in the throat, skin, or mucosa are the gateway for Group A Streptococcus (GAS) to penetrate our immune system. A significant inflammatory response to the heart is caused by an immunologic cascade triggered by GAS antigen cross-reactivity. This exaggerated immune response is primarily responsible for cardiac dysfunction. Recurrent inflammatory processes damage all layers of the heart, including the endocardium, myocardium, and pericardium. A vicious immunological cycle involving inflammatory mediators, angiotensin II, and TGF-\u03b2 promotes extracellular matrix remodeling, resulting in myocardial fibrosis. Myocardial fibrosis appears to be a prevalent occurrence in patients with RHD. The presence of myocardial fibrosis, which causes left ventricular dysfunction in RHD, might be utilized to determine options for treatment and might also be used to predict the outcome of interventions in patients with RHD. This emerging concept of myocardial fibrosis needs to be explored comprehensively in order to be optimally utilized in the treatment of RHD.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1230894","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T06:22:06Z","timestamp":1689747726000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Myocardial fibrosis in rheumatic heart disease: emerging concepts and clinical implications"],"prefix":"10.3389","volume":"10","author":[{"given":"Teuku Muhammad Haykal","family":"Putra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Rodriguez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wishnu Aditya","family":"Widodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Elfiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidhi","family":"Laksono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quang Ngoc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Wei Chieh","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagat","family":"Narula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/hrt.30.3.391","article-title":"Necropsy study of endomyocardial fibrosis and rheumatic heart disease in Uganda 1950-1965","volume":"30","author":"Shaper","year":"1968","journal-title":"Brit Heart J"},{"key":"B2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1590\/s0066-782\/1999000300006","article-title":"Mitral valve disease with rheumatic appearance in the presence of left ventricular endomyocardial fibrosis","volume":"72","author":"Saraiva","year":"1999","journal-title":"Arq Bras Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2020.00115","article-title":"Angiotensin converting enzyme inhibitors (ACEIs) decrease the progression of cardiac fibrosis in rheumatic heart disease through the inhibition of IL-33\/sSTS2","volume":"7","author":"Ambari","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","article-title":"Assessment of myocardial fibrosis with cardiovascular magnetic resonance","volume":"57","author":"Mewton","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"202","DOI":"10.30701\/ijc.v38i4.785","article-title":"Effect of myocardial fibrosis on left ventricular function in rheumatic mitral stenosis: a preliminary study with cardiac magnetic resonance","volume":"38","author":"Elen","year":"2017","journal-title":"Indonesian J Cardiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0039-1693457","article-title":"Prognostic value of late gadolinium enhancement in postoperative morbidity following mitral valves surgery in rheumatic mitral stenosis","volume":"28","author":"Putra","year":"2019","journal-title":"Int J Angiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s10554-018-1511-1","article-title":"Association between late gadolinium enhancement and global longitudinal strain in patients with rheumatic heart disease","volume":"35","author":"Soesanto","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e048016","DOI":"10.1136\/bmjopen-2020-048016","article-title":"Randomised controlled trial into the role of ramipril in fibrosis reduction in rheumatic heart disease: the RamiRHeD trial protocol","volume":"11","author":"Ambari","year":"2021","journal-title":"BMJ Open"},{"key":"B9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1056\/NEJMp078039","article-title":"Rheumatic heart disease in developing countries","volume":"357","author":"Carapetis","year":"2007","journal-title":"N Engl J Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJMoa1603693","article-title":"Global, regional and national burden of rheumatic heart disease, 1990-2015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Eng J Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0140-6736(05)66874-2","article-title":"Acute rheumatic fever","volume":"366","author":"Carapetis","year":"2005","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1030172","DOI":"10.3389\/fsurg.2022.1030172","article-title":"Editorial: new challenges with the management of rheumatic heart disease","volume":"9","author":"Soesanto","year":"2022","journal-title":"Front Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1540-8175.2009.01055.x","article-title":"High prevalence of rheumatic heart disease detected by echocardiography in school children","volume":"27","author":"Bhaya","year":"2010","journal-title":"Echocardiography"},{"key":"B15","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.acvd.2008.09.003","article-title":"Mitral stenosis still a concern in heart valve disease","volume":"101","author":"Lung","year":"2008","journal-title":"Arch Cardiovasc Dis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1056\/NEJMoa065085","article-title":"Prevalence of rheumatic heart disease detected by echocardiographic screening","volume":"357","author":"Marijon","year":"2007","journal-title":"N Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archinternmed.2012.3310","article-title":"The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries","volume":"172","author":"Damasceno","year":"2012","journal-title":"Arch Intern Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1136\/hrt.2007.118810","article-title":"Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa","volume":"93","author":"Nkomo","year":"2007","journal-title":"Heart"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/heartasia-2015-010641","article-title":"Rheumatic heart disease among adults in a mining community of Papua, Indonesia: findings from an occupational cohort","volume":"7","author":"Rodriguez-Fernandez","year":"2015","journal-title":"Heart Asia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.13181\/mji.oa.226150","article-title":"Characteristic of patients with rheumatic heart disease in a national referral hospital in Indonesia","volume":"31","author":"Rudiktyo","year":"2022","journal-title":"Med J Indones"},{"key":"B21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/ard.22.3.127","article-title":"Origin of the aschoff body","volume":"22","author":"Wedum","year":"1963","journal-title":"Ann Rheum Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1161\/01.cir.57.4.803","article-title":"Aschoff bodies at necropsy in valvular heart disease: evidence from an analysis of 543 patients over 14 years of age that rheumatic heart disease, at least anatomically, is a disease of the mitral valve","volume":"57","author":"Roberts","year":"1978","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/08830185.2014.917411","article-title":"Rheumatic fever, autoimmunity and molecular mimicry: the streptococcal connection","volume":"33","author":"Cunningham","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"15084","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2014.00140","article-title":"Responses of innate immune cells to group A Streptococcus","volume":"4","author":"Fieber","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/BOR.0b013e32835461d3","article-title":"Streptococcus and rheumatic fever","volume":"24","author":"Cunningham","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1126\/science.1154470","article-title":"Coiled-coil irregularities and instabilities in group A streptococcus M1 are required for virulence","volume":"319","author":"McNamara","year":"2008","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.4049\/jimmunol.176.9.5662","article-title":"Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease","volume":"176","author":"Fae","year":"2006","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1172\/JCI7132","article-title":"Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin","volume":"106","author":"Galvin","year":"2000","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/HCO.0000000000000269","article-title":"Update on rheumatic heart disease","volume":"31","author":"Yanagawa","year":"2016","journal-title":"Curr Opin Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fped.2014.00085","article-title":"Rethinking molecular mimicry in rheumatic heart disease and autoimmune myocarditis: laminin, collagen IV, CAR, and B1AR as initial targets of disease","volume":"2","author":"Root-Bernstein","year":"2014","journal-title":"Front Pediatr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1161\/01.cir.45.4.878","article-title":"Natural history of mitral stenosis: a review","volume":"45","author":"Selzer","year":"1972","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.120.050955","article-title":"Alternative hypothesis to explain disease progression in rheumatic heart disease","volume":"142","author":"Karthikeyan","year":"2020","journal-title":"Circulation"},{"key":"B34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3346\/jkms.2008.23.1.41","article-title":"Overexpression of transforming growth factor-\u03b21 in the valvular fibrosis of chronic rheumatic heart disease","volume":"23","author":"Kim","year":"2008","journal-title":"J Korean Med Sci"},{"key":"B35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/08916930500484674","article-title":"Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease","volume":"39","author":"Guilherme","year":"2006","journal-title":"Autoimmunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF01907583","article-title":"Ultrastructural and histological study of left ventricular myocardium in mitral stenosis","volume":"75","author":"Perennec","year":"1980","journal-title":"Basic Res Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1755-1536-5-15","article-title":"Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease","volume":"5","author":"Fan","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"B38","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10741-022-10279-x","article-title":"Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy","volume":"28","author":"Morfino","year":"2023","journal-title":"Heart Failure Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2010.02.047","article-title":"Assessment of nonischemic myocardial fibrosis","volume":"56","author":"Jellis","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jacc.2018.06.063","article-title":"Rheumatic heart disease worldwide: JACC scientific expert panel","volume":"72","author":"Watkins","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.addr.2019.05.011","article-title":"Cardiac fibrosis\u2014a short review of causes and therapeutic strategies","volume":"146","author":"Hinderer","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"B43","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"289243","DOI":"10.1155\/2012\/289243","article-title":"The roles of mitogen-activated protein kinase pathways in TGF-\u03b2-induced epithelial-mesenchymal transition","volume":"2012","author":"Gui","year":"2012","journal-title":"J Signal Transduct"},{"key":"B45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/MMBR.00031-10","article-title":"Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases","volume":"75","author":"Cargnello","year":"2011","journal-title":"Microbiol Mol Biol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nrcardio.2014.159","article-title":"Cardiac MRI: a central prognostic tool in myocardial fibrosis","volume":"12","author":"Ambale-Venkatesh","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10554-017-1195-y","article-title":"Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease","volume":"34","author":"Podleniskar","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"B49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ijcard.2006.04.013","article-title":"Detection of myocardial involvement of rheumatic heart disease with contrast-enhanced magnetic resonance imaging","volume":"113","author":"Choi","year":"2006","journal-title":"Int J Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"119","DOI":"10.18502\/jthc.v15i3.4222","article-title":"Left ventricular dimension after mitral valve surgery in rheumatic mitral stenosis: the impact of myocardial fibrosis","volume":"15","author":"Putra","year":"2020","journal-title":"J the Univ Heart Ctr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.21037\/qims-21-678","article-title":"Myocardial extracellular volume assessed by cardiovascular magnetic resonance may predict adverse left ventricular remodeling in rheumatic heart disease after valvular surgery","volume":"12","author":"Li","year":"2022","journal-title":"Quant Imaging Med Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11886-020-01288-z","article-title":"Soluble ST2 and soluble markers of fibrosis: emerging roles for prognosis and guiding therapy","volume":"22","author":"Sharim","year":"2020","journal-title":"Curr Cardiol Rep"},{"key":"B53","first-page":"22","article-title":"Evaluation of left ventricular long-axis function in cases of rheumatic pure mitral stenosis with atrial fibrillation","volume":"35","author":"Buyukkaya","year":"2008","journal-title":"Tex Heart Inst J"},{"key":"B54","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.hfc.2006.09.006","article-title":"Left ventricular dysfunction and mitral stenosis","volume":"2","author":"Klein","year":"2006","journal-title":"Heart Fail Clin"},{"key":"B55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/01.cir.67.1.148","article-title":"Left ventricular ejection performance and systolic muscle function in patients with mitral stenosis","volume":"67","author":"Gash","year":"1983","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1536\/ihj.31.435","article-title":"Ultrastructural pathological study of left ventricular myocardium in patients with isolated rheumatic mitral stenosis with normal or abnormal left ventricular function","volume":"31","author":"Lee","year":"1990","journal-title":"Jpn Heart J"},{"key":"B57","first-page":"1","article-title":"Determinants of depressed left ventricular ejection fraction in pure mitral stenosis with preserved sinus rhythm","volume":"51","author":"Surdacki","year":"1996","journal-title":"J Heart Valve Dis"},{"key":"B58","first-page":"75","article-title":"Impaired left ventricular systolic function in mitral stenosis","volume":"42","author":"Shikano","year":"2003","journal-title":"J Cardiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ehjci\/jeu253","article-title":"Role of two-dimensional strain and strain rate imaging in assessment of left ventricular systolic function in patients with rheumatic mitral stenosis and normal ejection fraction","volume":"67","author":"Younan","year":"2015","journal-title":"Egyptian Heart J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1161\/CIRCULATIONAHA.104.532498","article-title":"Modern management of mitral stenosis","volume":"112","author":"Carabello","year":"2005","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1378\/chest.64.5.609","article-title":"Left ventricular function in mitral stenosis","volume":"64","author":"Horwitz","year":"1973","journal-title":"Chest"},{"key":"B62","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000330404","article-title":"Severity of mitral stenosis and left ventricular mechanics: a speckle tracking study","volume":"119","author":"Bilen","year":"2011","journal-title":"Cardiology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/j.jtcvs.2014.02.082","article-title":"Effects of right ventricular morphology and function on outcomes of patients with degenerative mitral valve disease","volume":"148","author":"Ye","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B64","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1161\/01.cir.84.1.23","article-title":"Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size","volume":"84","author":"Reed","year":"1991","journal-title":"Circulation"},{"key":"B65","doi-asserted-by":"publisher","first-page":"674","DOI":"10.4103\/1110-2098.198753","article-title":"Evaluation of early outcomes after mitral replacement in rheumatic heart patients with pulmonary hypertension","volume":"29","author":"Dokhan","year":"2016","journal-title":"Menoufia Med J"},{"key":"B66","doi-asserted-by":"publisher","first-page":"559","DOI":"10.5935\/1678-9741.20110045","article-title":"Late outcomes of mitral repair in rheumatic patients","volume":"26","author":"Severino","year":"2011","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"B67","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/s1010-7940(98)00042-6","article-title":"High-risk mitral valve replacement in severe pulmonary hypertension\u201330 years experience","volume":"13","author":"Cesnjevar","year":"1998","journal-title":"Eur J Cardiothorac Surg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12968-016-0265-y","article-title":"Scar quantification by cardiovascular magnetic resonance as an independent predictor of long-term survival in patients with ischemic heart failure treated by coronary artery bypass graft surgery","volume":"18","author":"Kancharla","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.athoracsur.2014.06.049","article-title":"Prognostic value of delayed enhancement cardiac magnetic resonance imaging in mitral valve repair","volume":"98","author":"Chaikriangkrai","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"B70","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jacc.2014.02.612","article-title":"Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement","volume":"64","author":"Barone-Rochette","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.echo.2014.01.024","article-title":"Effects of percutaneous balloon mitral valvuloplasty on left ventricular deformation in patients with isolated severe mitral stenosis: a speckle-tracking strain echocardiographic study","volume":"27","author":"Sengupta","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B73","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/13543784.2021.1868432","article-title":"Cardiac fibrosis: emerging agents in preclinical and clinical development","volume":"30","author":"Spoladore","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"B74","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s40119-020-00199-y","article-title":"Myocardial fibrosis in heart failure: antifibrotic therapies and the role of cardiovascular magnetic resonance in drug trials","volume":"9","author":"Webber","year":"2020","journal-title":"Cardiol Ther"},{"key":"B75","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/000331970505600205","article-title":"Safety and efficacy of enalapril in multivalvular heart disease with significant mitral stenosis\u2014SCOPE-MS","volume":"56","author":"Chockalingam","year":"2005","journal-title":"Angiology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1753944716642677","article-title":"Cardiac remodelling and RAS inhibition","volume":"10","author":"Ferrario","year":"2016","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/ijpvm.IJPVM_322_16","article-title":"Effect of angiotensin-converting enzyme inhibitor on cardiac fibrosis and oxidative stress status in lipopolysaccharide-induced inflammation model in rats","volume":"8","author":"Abareshi","year":"2017","journal-title":"Int J Prev Med"},{"key":"B78","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/med\/9780198703341.003.0028","article-title":"Chapter 28: Heart failure\u2014CMR to assess viability","volume-title":"The ESC textbook of cardiovascular imaging","author":"Carpenter","year":"2015"},{"key":"B79","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.iccl.2018.03.005","article-title":"Myocardial viability testing to guide coronary revascularization","volume":"7","author":"Loffler","year":"2018","journal-title":"Interv Cardiol Clin"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/eurheartj\/ehn247","article-title":"Impact of coronary revascularization and transmural extent of scar on regional left ventricular remodelling","volume":"29","author":"Chan","year":"2008","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1230894\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T06:22:16Z","timestamp":1689747736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1230894\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":80,"alternative-id":["10.3389\/fcvm.2023.1230894"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1230894","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"article-number":"1230894"}}